This blog is maintained by Cristina Muñoz-Pinedo at IDIBELL, Barcelona.

Our lab is interested in the regulation of apoptosis by the glycolytic metabolism, and its aplication to cancer therapy. In particular, we are studying how inhibition of glycolysis triggers apoptosis and autophagy in tumors, and how inhibitors of glucose uptake sensitize tumor cells to chemotherapy. Moreover, we are studying the role of autophagy and endoplasmic reticulum stress in apoptosis and necrosis induced by glucose deprivation and ischemia.

If you are interested in working with us, please contact me at cmunoz (at) idibell.cat


4 thoughts on “About”

  1. Hello Cristina,
    Could you please share our most recent publication that details the outcome of our pre-clinical trial that tests mono-therapies and combinations therapies for ability to inhibit development of spontaneous breast cancer in a GEM model that is hyperactive for mTOR and cancer cell metabolism.
    Thank you.

    Oncotarget November 25, 2014.


  2. Muchas gracias, por añadirme al grupo, y por no poner mi nombre al revés.
    Para mi fue un placer conoceros. Lo pase muy bien.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Literature updates for researchers

%d bloggers like this: